EZZ Life Science Holdings Past Earnings Performance
Past criteria checks 5/6
EZZ Life Science Holdings has been growing earnings at an average annual rate of 32.7%, while the Life Sciences industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 31.2% per year. EZZ Life Science Holdings's return on equity is 32.7%, and it has net margins of 10.5%.
Key information
32.7%
Earnings growth rate
24.7%
EPS growth rate
| Life Sciences Industry Growth | 19.7% |
| Revenue growth rate | 31.2% |
| Return on equity | 32.7% |
| Net Margin | 10.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28
EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Revenue & Expenses Breakdown
How EZZ Life Science Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 66 | 7 | 38 | 0 |
| 31 Mar 24 | 55 | 5 | 32 | 0 |
| 31 Dec 23 | 44 | 3 | 26 | 0 |
| 30 Sep 23 | 40 | 4 | 24 | 0 |
| 30 Jun 23 | 37 | 4 | 22 | 0 |
| 31 Mar 23 | 31 | 3 | 16 | 0 |
| 31 Dec 22 | 24 | 3 | 11 | 0 |
| 30 Sep 22 | 19 | 2 | 7 | 0 |
| 30 Jun 22 | 15 | 1 | 4 | 0 |
| 31 Mar 22 | 15 | 1 | 5 | 0 |
| 31 Dec 21 | 16 | 1 | 5 | 0 |
| 30 Sep 21 | 19 | 1 | 7 | 0 |
| 30 Jun 21 | 22 | 2 | 9 | 0 |
| 31 Mar 21 | 22 | 2 | 7 | 0 |
| 31 Dec 20 | 21 | 2 | 6 | 0 |
| 30 Sep 20 | 20 | 2 | 4 | 0 |
| 30 Jun 20 | 18 | 2 | 2 | 0 |
| 30 Jun 19 | 11 | 1 | 3 | 0 |
Quality Earnings: EZZ has a high level of non-cash earnings.
Growing Profit Margin: EZZ's current net profit margins (10.5%) are higher than last year (9.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EZZ's earnings have grown significantly by 32.7% per year over the past 5 years.
Accelerating Growth: EZZ's earnings growth over the past year (91.9%) exceeds its 5-year average (32.7% per year).
Earnings vs Industry: EZZ earnings growth over the past year (91.9%) exceeded the Life Sciences industry -6.7%.
Return on Equity
High ROE: EZZ's Return on Equity (32.7%) is considered high.